Kezar Life Sciences (KZR) Invested Capital (2021 - 2025)
Historic Invested Capital for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $88.3 million.
- Kezar Life Sciences' Invested Capital fell 3602.95% to $88.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.3 million, marking a year-over-year decrease of 3602.95%. This contributed to the annual value of $122.1 million for FY2024, which is 3818.24% down from last year.
- According to the latest figures from Q3 2025, Kezar Life Sciences' Invested Capital is $88.3 million, which was down 3602.95% from $97.1 million recorded in Q2 2025.
- In the past 5 years, Kezar Life Sciences' Invested Capital registered a high of $307.4 million during Q2 2022, and its lowest value of $88.3 million during Q3 2025.
- Its 5-year average for Invested Capital is $185.5 million, with a median of $170.4 million in 2024.
- In the last 5 years, Kezar Life Sciences' Invested Capital skyrocketed by 14538.46% in 2022 and then crashed by 3895.32% in 2024.
- Over the past 5 years, Kezar Life Sciences' Invested Capital (Quarter) stood at $206.9 million in 2021, then surged by 35.28% to $279.9 million in 2022, then fell by 29.41% to $197.6 million in 2023, then plummeted by 38.18% to $122.1 million in 2024, then fell by 27.74% to $88.3 million in 2025.
- Its last three reported values are $88.3 million in Q3 2025, $97.1 million for Q2 2025, and $108.3 million during Q1 2025.